Karanlik, H. Et Al. 2013. Which cytologically proven node-positive breast cancer patients can avoid axillary lymph dissection after neaodjuvant chemotherapy?. CANCER RESEARCH , vol.73 .

Karanlik, H., Ilhan, B., Fayda, M., Yavuz, E., Mudun, A., Saip, P., ... Eralp, Y.(2013). Which cytologically proven node-positive breast cancer patients can avoid axillary lymph dissection after neaodjuvant chemotherapy?. CANCER RESEARCH , vol.73.

Karanlik, H. Et Al. "Which cytologically proven node-positive breast cancer patients can avoid axillary lymph dissection after neaodjuvant chemotherapy?," CANCER RESEARCH , vol.73, 2013

Karanlik, H. Et Al. "Which cytologically proven node-positive breast cancer patients can avoid axillary lymph dissection after neaodjuvant chemotherapy?." CANCER RESEARCH , vol.73, 2013

Karanlik, H. Et Al. (2013) . "Which cytologically proven node-positive breast cancer patients can avoid axillary lymph dissection after neaodjuvant chemotherapy?." CANCER RESEARCH , vol.73.

@article{article, author={H. Karanlik Et Al. }, title={Which cytologically proven node-positive breast cancer patients can avoid axillary lymph dissection after neaodjuvant chemotherapy?}, journal={CANCER RESEARCH}, year=2013}